Fundz

Neurogastrx, Inc. reported raising $60 Million in an initial SEC Form D filing

PRIVATEJul 13, 2021

Amount Raised

$60 Million

$60 Million sold, per SEC Form D (first sale Jul 13, 2021)

Round Type

Venture

WoburnBiotechnologyHealth CareScience And EngineeringInternet Services

Quick answer

Neurogastrx raised $60 Million in a funding round, dated July 13, 2021. Neurogastrx is based in Woburn, Massachusetts, United States.

How much did Neurogastrx raise?
Neurogastrx raised $60 Million in a funding round on July 13, 2021.
What does Neurogastrx do?
Neurogastrx, Inc. is a privately held specialty pharmaceutical company developing transformative therapies to advance the treatment of GI disorders for which meaningful therapeutic innovation is required to satisfy..
Where is Neurogastrx based and how big is it?
Neurogastrx is based in Woburn, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Internet Services around the same time

Companies in the same sectors as Neurogastrx that raised within 45 days of this round, from Fundz verified event records.

  • Psilera raised $2.5M (Seed) on August 26, 2021.
  • Atavistik Bio raised $60M (Series A) on August 24, 2021.
  • Sydnexis raised $46M on August 18, 2021.
  • PBS Biotech raised $10M (Funding Round) on August 16, 2021.
  • Sydnexis raised $45M (Series B) on August 10, 2021.
  • Appili Therapeutics Inc. raised $3.5M (Seed) on August 9, 2021.

Who to call at Neurogastrx, and when

A new round usually means Neurogastrx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neurogastrx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurogastrx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurogastrx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurogastrx

Location

Woburn, Massachusetts, United States

About

Neurogastrx, Inc. is a privately held specialty pharmaceutical company developing transformative therapies to advance the treatment of GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden. For more information, visit the company’s website at www.neurogastrx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurogastrx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neurogastrx's next move

See what Strategic adds

Neurogastrx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.